MEDB-31. THE CLINICAL SIGNIFICANCE OF EXTENT OF RESECTION IN MEDULLOBLASTOMA

por Keeling, Claire, Davies, Simon, Hicks, Debbie, Clifford, Steven
Publicado 2022

OMIC-06. MOLECULAR SUBGROUPING OF MEDULLOBLASTOMA VIA LOW-DEPTH WHOLE GENOME BISULFITE SEQUENCING

por Thompson, Dean, Castle, Jemma, Hicks, Debbie, Clifford, Steve, Schwalbe, Ed
Publicado 2021

PATH-06. Molecular subgrouping of medulloblastoma via low-depth whole genome bisulfite sequencing

por Thompson, Dean, Castle, Jemma, Hicks, Debbie, Schwalbe, Ed, Clifford, Steve
Publicado 2022

Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes

por Evans, Marc, Hicks, Debbie, Patel, Dipesh, Patel, Vinod, McEwan, Phil, Dashora, Umesh
Publicado 2019

MEDB-65. Molecular subclassification of a national cohort of pediatric medulloblastoma based on methylation profile

por Alaña, Lide, Martin-Guerrero, Idoia, Navajas, Aurora, Zaldumbide, Laura, Mosteiro, Lorena, Schwalbe, Edward C, Hicks, Debbie, Clifford, Steven C, García-Ariza, Miguel
Publicado 2022

SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice

por Wilding, John, Fernando, Kevin, Milne, Nicola, Evans, Marc, Ali, Amar, Bain, Steve, Hicks, Debbie, James, June, Newland-Jones, Philip, Patel, Dipesh, Viljoen, Adie
Publicado 2018

QOL-17. BIOLOGICAL CORRELATES OF QUALITY OF SURVIVAL AND NEUROCOGNITIVE OUTCOMES IN MEDULLOBLASTOMA; A META-ANALYSIS OF THE SIOP-UKCCSG-PNET3 AND HIT-SIOP-PNET4 TRIALS

por Chevignard, Mathilde, Bull, Kim, Holt, James, Heng, Marie-Amelie, Kennedy, Colin, Doz, Francois, Lannering, Birgitta, Rutkowski, Stefan, Massimino, Maura, Clifford, Steven, Hicks, Debbie
Publicado 2020

Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice

por Ali, Amar, Bain, Steve, Hicks, Debbie, Newland Jones, Phillip, Patel, Dipesh C., Evans, Marc, Fernando, Kevin, James, June, Milne, Nicola, Viljoen, Adie, Wilding, John
Publicado 2019

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice

por Ali, Amar, Bain, Steve, Hicks, Debbie, Newland Jones, Phillip, Patel, Dipesh C., Evans, Marc, Fernando, Kevin, James, June, Milne, Nicola, Viljoen, Adie, Wilding, John
Publicado 2019

SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes

por Wheeler, David C., James, June, Patel, Dipesh, Viljoen, Adie, Ali, Amar, Evans, Marc, Fernando, Kevin, Hicks, Debbie, Milne, Nicola, Newland-Jones, Philip, Wilding, John
Publicado 2020

Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical Practice

por Evans, Marc, Morgan, Angharad R., Bain, Stephen C., Davies, Sarah, Hicks, Debbie, Brown, Pam, Yousef, Zaheer, Dashora, Umesh, Viljoen, Adie, Beba, Hannah, Strain, W. David
Publicado 2022

Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial

por Goschzik, Tobias, Schwalbe, Edward C, Hicks, Debbie, Smith, Amanda, zur Muehlen, Anja, Figarella-Branger, Dominique, Doz, François, Rutkowski, Stefan, Lannering, Birgitta, Pietsch, Torsten, Clifford, Steven C
Publicado 2018

Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related Complications

por Evans, Marc, Morgan, Angharad R., Patel, Dipesh, Dhatariya, Ketan, Greenwood, Sharlene, Newland-Jones, Philip, Hicks, Debbie, Yousef, Zaheer, Moore, Jim, Kelly, Bethany, Davies, Sarah, Dashora, Umesh
Publicado 2020

Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial

por Clifford, Steven C., Lannering, Birgitta, Schwalbe, Ed C., Hicks, Debbie, O' Toole, Kieran, Nicholson, Sarah Leigh, Goschzik, Tobias, zur Mühlen, Anja, Figarella-Branger, Dominique, Doz, François, Rutkowski, Stefan, Gustafsson, Göran, Pietsch, Torsten
Publicado 2015

MBRS-44. TIME, PATTERN AND OUTCOME OF MEDULLOBLASTOMA RELAPSE ARE ASSOCIATED WITH TUMOUR BIOLOGY AT DIAGNOSIS AND UPFRONT THERAPY: A COHORT STUDY

por Hill, Rebecca, Richardson, Stacey, Schwalbe, Edward, Hicks, Debbie, Lindsey, Janet, Crosier, Stephen, Rafiee, Gholamreza, Grabovska, Yura, Wharton, Stephen, Jacques, Thomas, Michalski, Anthony, Joshi, Abhijit, Pizer, Barry, Williamson, Daniel, Bailey, Simon, Clifford, Steven
Publicado 2020

EMBR-25. GENOME-WIDE GENETIC AND EPIGENETIC ASSESSMENT OF GROUP 4 MEDULLOBLASTOMA FOR IMPROVED, BIOMARKER DRIVEN, PROGNOSTICATION AND RISK-STRATIFICATION

por Goddard, Jack, Castle, Jemma, Southworth, Emily, Crosier, Stephen, Martin-Guerrero, Idoia, Garcia-Ariza, Miguel, Navajas, Aurora, Bourdeaut, Franck, Dufour, Christelle, Goschzik, Tobias, Pietsch, Torsten, Williamson, Dan, Bailey, Simon, Schwalbe, Ed, Clifford, Steven, Hicks, Debbie
Publicado 2021

Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy

por Harris, Elizabeth, Topf, Ana, Barresi, Rita, Hudson, Judith, Powell, Helen, Tellez, James, Hicks, Debbie, Porter, Anna, Bertoli, Marta, Evangelista, Teresinha, Marini-Betollo, Chiara, Magnússon, Ólafur, Lek, Monkol, MacArthur, Daniel, Bushby, Kate, Lochmüller, Hanns, Straub, Volker
Publicado 2017

MBRS-69. METABOLITE PROFILING OF SHH MEDULLOBLASTOMA IDENTIFIES A SUBSET OF CHILDHOOD TUMOURS ENRICHED FOR HIGH-RISK MOLECULAR BIOMARKERS AND CLINICAL FEATURES

por Bennett, Christopher, Kohe, Sarah, Burte, Florence, Rose, Heather, Hicks, Debbie, Schwalbe, Ed, Crosier, Stephen, Storer, Lisa, Lourdusamy, Anbarasu, Wilson, Martin, Avula, Shivaram, Mitra, Dipayan, Dineen, Robert, Bailey, Simon, Williamson, Daniel, Grundy, Richard, Clifford, Steven, Peet, Andrew
Publicado 2020

Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study

por Hill, Rebecca M, Richardson, Stacey, Schwalbe, Edward C, Hicks, Debbie, Lindsey, Janet C, Crosier, Stephen, Rafiee, Gholamreza, Grabovska, Yura, Wharton, Stephen B, Jacques, Thomas S, Michalski, Antony, Joshi, Abhijit, Pizer, Barry, Williamson, Daniel, Bailey, Simon, Clifford, Steven C
Publicado 2020

Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics

por Crosier, Stephen, Hicks, Debbie, Schwalbe, Edward C., Williamson, Daniel, Leigh Nicholson, Sarah, Smith, Amanda, Lindsey, Janet C., Michalski, Antony, Pizer, Barry, Bailey, Simon, Bown, Nick, Cuthbert, Gavin, Wharton, Stephen B., Jacques, Thomas S., Joshi, Abhijit, Clifford, Steven C.
Publicado 2021